CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
Wang
Min
M
Xiao
Juan
J
Jiang
Jianxin
J
Qin
Renyi
R
D000071916:AC133 Antigen; D000444:Aldehyde Dehydrogenase / Q000378:metabolism*; D000080924:Aldehyde Dehydrogenase 1 Family; D015703:Antigens, CD / Q000378:metabolism*; D001650:Bile Duct Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D001653:Bile Ducts, Intrahepatic / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D018281:Cholangiocarcinoma / Q000175:diagnosis / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism*; D014411:Neoplastic Stem Cells / Q000473:pathology*; D010455:Peptides / Q000378:metabolism*; D011379:Prognosis; D050697:Retinal Dehydrogenase
D000071916:AC133 Antigen; D015703:Antigens, CD; D014408:Biomarkers, Tumor; D006023:Glycoproteins; D007527:Isoenzymes; C000606023:PROM1 protein, human; D010455:Peptides; D000080924:Aldehyde Dehydrogenase 1 Family; D000444:Aldehyde Dehydrogenase; C510223:ALDH1A1 protein, human; D050697:Retinal Dehydrogenase